Cresset Asset Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14M Buy
116,003
+2,170
+2% +$263K 0.06% 186
2025
Q1
$13.1M Buy
113,833
+77,048
+209% +$8.89M 0.07% 186
2024
Q4
$3.58M Sell
36,785
-41,353
-53% -$4.02M 0.02% 401
2024
Q3
$8.99M Buy
78,138
+8,452
+12% +$972K 0.03% 328
2024
Q2
$7.42M Buy
69,686
+9,407
+16% +$1M 0.03% 341
2024
Q1
$6.05M Buy
60,279
+2,647
+5% +$266K 0.03% 346
2023
Q4
$5.82M Buy
57,632
+1,870
+3% +$189K 0.03% 302
2023
Q3
$5.68M Buy
55,762
+2,687
+5% +$274K 0.02% 282
2023
Q2
$5.36M Buy
53,075
+32,816
+162% +$3.31M 0.01% 302
2023
Q1
$1.86M Buy
20,259
+167
+0.8% +$15.4K 0.04% 240
2022
Q4
$1.81M Sell
20,092
-3,448
-15% -$310K 0.02% 212
2022
Q3
$1.79M Sell
23,540
-119
-0.5% -$9.05K 0.02% 229
2022
Q2
$2M Sell
23,659
-1,011
-4% -$85.4K 0.02% 229
2022
Q1
$2.17M Buy
24,670
+712
+3% +$62.5K 0.02% 234
2021
Q4
$2.1M Sell
23,958
-2,004
-8% -$175K 0.02% 290
2021
Q3
$2.12M Buy
25,962
+5,478
+27% +$448K 0.03% 222
2021
Q2
$1.87M Sell
20,484
-7,321
-26% -$668K 0.03% 214
2021
Q1
$2.38M Buy
27,805
+2,145
+8% +$183K 0.04% 152
2020
Q4
$2.42M Buy
25,660
+4,107
+19% +$388K 0.04% 140
2020
Q3
$1.87M Sell
21,553
-4,053
-16% -$352K 0.04% 171
2020
Q2
$2.24M Buy
25,606
+17,432
+213% +$1.52M 0.05% 138
2020
Q1
$674K Buy
8,174
+601
+8% +$49.6K 0.02% 240
2019
Q4
$717K Sell
7,573
-108
-1% -$10.2K 0.02% 251
2019
Q3
$667K Buy
7,681
+2,999
+64% +$260K 0.02% 225
2019
Q2
$428K Sell
4,682
-1,575
-25% -$144K 0.01% 270
2019
Q1
$539K Buy
6,257
+2,681
+75% +$231K 0.02% 177
2018
Q4
$275K Buy
+3,576
New +$275K 0.02% 170